Posts

Posted on

Lost Money in Qiwi PLC?

Lost Money in Qiwi PLC?

Gibbs Law Group Investigates Potential Securities Law Violations

OAKLAND, Calif.–(BUSINESS WIRE)–
Qiwi PLC shares dropped 20% in intraday trading following its SEC filing announcing that during a routine scheduled audit, the Central Bank of Russia identified certain violations and deficiencies relating primarily to reporting and record-keeping requirements. Gibbs Law Group is investigating a potential Qiwi Securities Class Action Lawsuit on behalf of investors who lost money in Qiwi PLC (NASDAQ:QIWI).

To speak with an attorney regarding this class action lawsuit investigation, click here, or call (888) 410-2925.

On Wednesday, December 9, 2020, Qiwi PLC announced in an SEC filing that the Central Bank of Russia performed a routine scheduled audit of Qiwi Bank JSC (“Qiwi Bank”) for the period of July 2018 to September 2020 and identified certain violations and deficiencies relating primarily to “reporting and record-keeping requirements.” Upon this audit finding, the Central Bank of Russia imposed a fine of approximately $150,000 on the company and has suspended or limited most types of payments to foreign merchants and money transfers to pre-paid cards from corporate accounts, effective December 7, 2020. The next morning, J.P. Morgan downgraded Qiwi stock from neutral to underweight. On this news, Qiwi’s stocks dropped 20% in intraday trading on December 10, 2020, causing significant harm to investors.

What ShouldQiwi Investors Do?

If you invested in Qiwi, visit our website or contact our securities team directly at (888) 410-2925 to discuss how you may be able to recover your losses. Our investigation concerns whether Qiwi PLC has violated federal securities laws and failed to disclose information pertinent to investors.

About Gibbs Law Group

Gibbs Law Group represents individual and institutional investors throughout the country in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Top Class Action Attorneys Under 40,” “Consumer Protection MVP,” and “Top Cybersecurity/ Privacy Attorneys Under 40.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

EILEEN EPSTEIN

PHONE: 510.350.9728

EMAIL: [email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

TRQ FINAL DEADLINE ALERT: Top Ranked Rosen Law Firm Reminds Turquoise Hill Resources Ltd. Investors of Important December 14 Deadline in Securities Class Action – TRQ

PR Newswire

NEW YORK, Dec. 10, 2020 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Turquoise Hill Resources Ltd. (NYSE: TRQ) between July 17, 2018 and July 31, 2019, inclusive (the “Class Period”), of the important December 14, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Turquoise Hill investors under the federal securities laws.

To join the Turquoise Hill class action, go to http://www.rosenlegal.com/cases-register-1971.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

According to the lawsuit, throughout the Class Period and regarding the development of the Oyu Tolgoi copper-gold mine in Mongolia, defendants made false and/or misleading statements and/or failed to disclose that: (1) the stability issues were much more severe than represented and called into question the design of the mine, the projected cost and timing of production; (2) the publicly disclosed estimates of the cost, date of completion and dates for production from the underground mine were not achievable; (3) the “challenging ground conditions” were much more severe than defendants represented, and in fact made it impossible for Turquoise Hill and Rio Tinto to achieve those estimates; (4) the development capital required for the underground development of Oyu Tolgoi would cost substantially more than a billion dollars over what Turquoise Hill and Rio Tinto had represented; (5) Turquoise Hill would require additional financing and/or equity to complete the project; (6) the progress of underground development and of Oyu Tolgoi was not proceeding as planned; and (7) the “key risks” had not been “well understood and managed” but had placed the project schedule and cost into severe jeopardy. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1971.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/trq-final-deadline-alert-top-ranked-rosen-law-firm-reminds-turquoise-hill-resources-ltd-investors-of-important-december-14-deadline-in-securities-class-action–trq-301190919.html

SOURCE Rosen Law Firm, P.A.

Posted on

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif.–(BUSINESS WIRE)–
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases, today announced that the Compensation Committee of Mirum’s Board of Directors granted a non-qualified stock option award to purchase an aggregate of 11,300 shares of common stock to one new employee under Mirum’s 2020 Inducement Plan. The Compensation Committee of Mirum’s Board of Directors approved the awards as an inducement material to the new employee’s employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Each stock option has an exercise price per share equal to $24.93 per share, Mirum’s closing trading price on December 10, 2020, and will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the applicable vesting commencement date and the balance of the underlying shares vesting monthly thereafter over 36 months, subject to the new employee’s continued service relationship with Mirum through the applicable vesting dates. The award is subject to the terms and conditions of Mirum’s 2020 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant.

About Mirum Pharmaceuticals

Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Mirum’s lead product candidate, maralixibat, is an investigational oral drug in development for Alagille syndrome (ALGS), progressive familial intrahepatic cholestasis (PFIC), and biliary atresia. Mirum has initiated a rolling NDA submission for maralixibat in the treatment of cholestatic pruritus in patients with ALGS and expects to complete the submission in the first quarter of 2021. Additionally, Mirum’s marketing authorization application for the treatment of pediatric patients with PFIC2 has been accepted for review (validated) by the European Medicines Agency.

Mirum is also developing volixibat, also an oral ASBT-inhibitor, in primary sclerosing cholangitis and intrahepatic cholestasis of pregnancy. For more information, visit MirumPharma.com.

Follow Mirum on Twitter, Facebook, LinkedIn and Instagram.

Investor Contact:

Ian Clements, Ph.D.

[email protected]

Media Contact:

Erin Murphy

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Biotechnology Pharmaceutical Health

MEDIA:

Logo
Logo
Posted on

Ogilvy Appoints New Global Finance & People Leadership

PR Newswire

NEW YORK, Dec. 10, 2020 /PRNewswire/ — Ogilvy today announced new members of its global leadership team with the appointments of Stacey Ryan-Cornelius as Global Chief Financial Officer and Jag Dhanji as Global Chief People Officer.

“Stacey is not only a seasoned leader with vast experience and creative commercial acumen, but also a leader experienced in business transformation and growth. We’re thrilled to have her back at Ogilvy as we focus on being the best platform and partner for growth, delivering speed to value for our clients with world-class creative thinking,” said Andy Main, Global CEO of Ogilvy. “When we grow our business, and that of our clients, it is because of Ogilvy’s ability to attract, nurture, and retain the best talent in the industry. Jag’s experience working across fast-moving organizations and industries, and the passion she has shown for building a culture at Ogilvy that empowers people to do their best work, will be an amazing asset to our team.”

“As we think about the future of the industry, Andy’s vision coupled with Ogilvy’s world class creativity and range of capabilities is a compelling proposition for our clients. I’m really excited to be coming back to Ogilvy as it embarks on the next stage of its evolution,” Stacey said. “I’m also looking forward to partnering with Andy, Jag, and other leaders to drive meaningful, and lasting progress when it comes to diversity, equity, and inclusion.”

“We are living through a unique moment where we are completely rethinking the way we live and work, which makes this opportunity so invigorating,” Jag noted. “Ogilvy has some of the best creative and strategic talent in the world and I’m excited to work with my colleagues across the globe to ensure that Ogilvy remains a ‘company of giants’ with a culture that is innovative, inclusive, and fun.”

Stacey succeeds Steve Goldstein, who is retiring from the business and will stay on for a transition period through early 2021; Jag takes over for Brian Fetherstonhaugh. Stacey and Jag will both report to Andy Main as well as WPP Chief Financial Officer John Rogers and WPP Chief People Officer Jacqui Canney respectively; they will also join the WPP Finance and People leadership teams.


Stacey Ryan Cornelius
 most recently served as Global Chief Financial Officer and Chief Operating Officer of Geometry Global, WPP’s end to end Creative Commerce Agency, where she was a driving force behind the agency’s transformation. In addition to putting people and systems in place to enable operational efficiency and sustainable agency growth, Stacey played an important role in the deployment of a distinct and advanced technology platform, Living Commerce™, to establish a new way of working that is agile, collaborative and reflects the needs of today’s modern marketers. Prior to that, Stacey was Global Chief Financial Officer of WPP Health & Wellness where she spent 15 months restructuring the portfolio, executing key transformation initiatives, and delivering financial and strategic direction across 64 operating units in the US, Canada, EMEA and Asia.

Stacey originally joined Ogilvy in 1999 and held various regional and global leadership roles, including serving as the company’s Worldwide Controller until 2018. She began her career at PricewaterhouseCoopers where she consulted on financial statement audits, mergers & acquisitions and IPO’s for a range of major multinational advertising and publishing clients from Ziff-Davis Publishing and Simon & Schuster to Viacom’s MTV Network and PBS’s Children’s Television Workshop.

Stacey has been featured by Black Enterprise Magazine as one of the 75 Most Powerful Women in Business and is often called upon to speak about diversity and inclusion, and the importance of increased representation across all levels of the marketing and communications industry.

Jag Dhanji joined Ogilvy in October 2017 as Chief Talent Officer for Europe, the Middle East and Africa. Jag is a seasoned leader that has commercial experience working across a number of international companies and industries including Diageo, Vodafone and Costa. She has worked with diverse teams including the Global Marketing and Innovation team at Diageo, the India leadership team at Vodafone, as well as the International team at Costa.

Jag has a passion for building enduring and sustainable organizations – throughout her career she has helped organizations to evolve and grow, building strong diverse talent pipelines and developed the key asset of any organization, their people. Jag has led teams worldwide and has worked and lived in Europe, South Africa and India. 


About Ogilvy

Ogilvy has been producing iconic, culture-changing marketing campaigns since the day its founder David Ogilvy opened up shop in 1948. Today, Ogilvy is an award-winning integrated creative network that makes brands matter for Fortune Global 500 companies as well as local businesses across 132 offices in 83 countries. Ogilvy is a WPP company (NASDAQ: WPPGY). For more information, visit Ogilvy.com, or follow Ogilvy on Twitter at @Ogilvy and on Facebook.com/Ogilvy.

Media Contacts: David Ford / [email protected] 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ogilvy-appoints-new-global-finance–people-leadership-301190924.html

SOURCE Ogilvy

Posted on

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos Therapeutics, Inc.

PR Newswire

NEW YORK, Dec. 10, 2020 /PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Neos Therapeutics, Inc. (NASDAQ: NEOS) and its board of directors concerning the proposed acquisition of the company by Aytu BioScience, Inc. (NASDAQ: AYTU). Stockholders will receive 0.1088 shares of Aytu BioScience common stock for each share of Neos Therapeutics stock that they hold. The transaction is valued at approximately $44.9 million and is expected to close by the second quarter of 2021.

If you are a stockholder of Neos Therapeutics, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/neos/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at [email protected], or by telephone at 914-400-1920 or 844-400-4643 (toll-free).  

Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com. 

Attorney Advertising. Prior results do not guarantee a similar outcome.

Cision View original content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-neos-therapeutics-inc-301190921.html

SOURCE Rowley Law PLLC

Posted on

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Covia Holdings Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Covia Holdings Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Covia Holdings Corporation (“Covia” or “the Company”) (OTC: CVIAQ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between March 15, 2016 and June 29, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before February 8, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Covia touted its “value-added” proprietary proppants that failed to be any more effective than ordinary sand. The Company’s revenues were dependent on its proprietary proppant, which it misrepresented to the market. When Company insiders raised issues with the proppants, it did not take action to rectify the situation. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Covia, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.

www.schallfirm.com

Office: 310-301-3335

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Equus Announces Pending Sale of Its Interest in Palletone, Inc.

HOUSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Company”) today announced that the Board of Directors of UFP Industries, Inc. (Nasdaq: UFPI) has approved the purchase of 100% of the equity of PalletOne, Inc. for approximately $232 million. The price assumes a cash free, debt free balance sheet. UFP also agreed to pay $18 million for PalletOne’s recent capital expenditures. The transaction is subject to a net working capital adjustment and is expected to close on December 28, 2020 pending customary closing conditions and regulatory approval.

In October 2001, Equus made its initial investment in PalletOne and was one of two institutional funds to finance the creation of PalletOne from certain of the remnants of a former pallet manufacturing conglomerate. PalletOne has since risen to become one of the largest wooden pallet manufacturers in the United States and a major regional supplier of treated wood to retail lumber outlets and home improvement stores in the Southeastern U.S. In recent years, Equus has worked closely with the management team and board of PalletOne to monetize its investment, and today’s announcement is a culmination of these efforts.

“We have appreciated the investment of Equus in PalletOne, and in recent years John Hardy’s advice and assistance as we have worked to achieve an exit for the stockholders,” said Howe Wallace, CEO of PalletOne.

“We have enjoyed working with PalletOne over the years and, in particular, with its management team led by Howe Wallace who has transformed the company into an industry leader in pallet manufacturing and treated wood products,” said John Hardy, CEO of Equus. “We wish them the best as they transition to capitalize on new and exciting opportunities in the industry.”

Forward-Looking Statements

This press release contains certain forward-looking statements regarding possible future circumstances. These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements including, in particular, the performance of the Company, including our ability to achieve our expected financial and business objectives, the other risks and uncertainties described herein, as well as those contained in the Company’s filings with the SEC. Actual results, events, and performance may differ. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.

Contacts:

Patricia Baronowski
Pristine Advisers, LLC
(631) 756-2486



Posted on

ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Qiwi plc; Encourages Investors with Losses in Excess of $100K to Contact the Firm – QIWI

ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Qiwi plc; Encourages Investors with Losses in Excess of $100K to Contact the Firm – QIWI

NEW YORK–(BUSINESS WIRE)–
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Qiwi plc (NASDAQ: QIWI) resulting from allegations that Qiwi may have issued materially misleading business information to the investing public.

On December 10, 2020, Qiwi issued a press release entitled “QIWI (QIWI) Fined by Bank of Russia, Restricts Operations.” The press release stated, in relevant part, that “[f]rom July to December 2020, the Central Bank of Russia (‘CBR’), acting in its supervisory capacity, performed a routine scheduled audit of Qiwi Bank JSC (‘Qiwi Bank’) for the period of July 2018 to September 2020 and, in the course of this audit, has identified certain violations and deficiencies relating primarily to reporting and record-keeping requirements. . . . The monetary fine imposed on Qiwi Bank as a result of these findings was RUB 11 million, or approximately USD 150,000.” Qiwi further disclosed that “as part of its instruction letter setting forth the findings of the audit, the CBR introduced certain restrictions with respect to Qiwi Bank’s operations, including, effective from December 7, 2020, the suspension or limitation of most types of payments to foreign merchants and money transfers to pre-paid cards from corporate accounts.”

On this news, Qiwi’s ADR price fell $2.80 per share, or 20.6%, to close at $10.79 per share on December 10, 2020.

Rosen Law Firm is preparing a securities lawsuit on behalf of Qiwi shareholders. If you purchased securities of Qiwi please visit the firm’s website at http://www.rosenlegal.com/cases-register-2005.html to join the securities action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

[email protected]

[email protected]

www.rosenlegal.com

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Winners Announced for Eye Level Literary Award 2020

PR Newswire

SEOUL, South Korea, Dec. 10, 2020 /PRNewswire/ — On December 4, 2020, Daekyo Culture Foundation successfully held its 28th Eye Level Literary Award (ELLA) ceremony at Daekyo Tower in Seoul. This year’s ceremony was broadcast online due to the pandemic. Only key staff members and local winners were present at the ceremony, adhering to strict health protocols.

For the past 28 years, Daekyo Culture Foundation has sponsored the event to discover new authors and to cultivate children’s creativity. 10,000 applications from 10 countries were received this year. Among them 87 were selected as awardees in the following categories: Literature for Children, Children’s Poetry, Teen Literary Composition, and Global.

For the global category, 6 children were selected as winners. This year’s topic asked children how COVID-19 has affected their daily lives. Submissions dealt with themes ranging from virtual learning to unemployment. For the Illustrated Writing subcategory, the grand prize goes to Hannah Chen (6, Mainland China), Silver to Ally Zi Xin Lim (4, Singapore), and Bronze to Surabhi Srikumar (6, India). In the Writing subcategory for seniors, Zabrina Yu Yiu Chau (11, Hong Kong) receives the Grand prize, Amaar Halani (12, U.S.A) receives silver, and Zay Lin Phyo (12, Myanmar) receives bronze. All winners receive a cash prize.

The grand prize for the Teen Literary Composition, a new category, goes to Na Hyun Kwon (18, Korea) from Anyang Arts High School.

The Children’s Poetry category saw 63 prize recipients. The grand prize winner is Ji In Choi (10, Korea) from Incheon Myeong Sun elementary school.

Lastly, in the Literature for Children category, 5 up-and-coming authors were chosen as winners in which 3 are from the “Fairy Tale” subcategory and 2 are from the “Picture Book” subcategory.

To learn more about other events by Eye Level or Daekyo Culture Foundation, visit myeyelevel.com.

About Eye Level

More than 2.8 million children from 20 countries have experienced the Eye Level program.

Our teaching philosophy begins with understanding each child’s academic level, personal interests, and learning ability. Thereafter, our staff helps students master each concept through one-on-one coaching via our small-step approach. At Eye Level, we help young learners become self-directed problem solvers, critical thinkers, and lifelong learners — setting them up for success in school and beyond.

Contact:

Name: Kenneth Chang
Phone: +8228290334

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/winners-announced-for-eye-level-literary-award-2020-301190001.html

SOURCE Eye Level

Posted on

Certara Announces Pricing of Its Upsized Initial Public Offering

Certara Announces Pricing of Its Upsized Initial Public Offering

PRINCETON, N.J.–(BUSINESS WIRE)–
Certara, Inc. (“Certara”), a global leader in biosimulation, today announced the pricing of its upsized initial public offering of 29,055,000 shares of its common stock at $23.00 per share. Certara is offering 14,630,000 shares of its common stock and certain selling stockholders are offering 14,425,000 shares of common stock in the offering. Shares of Certara’s common stock are expected to begin trading on The Nasdaq Global Select Market on December 11, 2020, under the ticker symbol “CERT,” and the offering is expected to close on December 15, 2020, subject to customary closing conditions. The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 4,358,250 shares of common stock at the initial public offering price less the underwriting discounts and commissions. The gross proceeds to Certara from the offering will be approximately $336.5 million, before deducting the underwriting discount and estimated offering expenses. Certara will not receive any proceeds from any sale of shares in the offering by the selling stockholders.

The offering is being made through an underwriting group led by Jefferies, Morgan Stanley and BofA Securities, who are acting as lead joint book-running managers, and Credit Suisse, Barclays and William Blair, who are acting as joint book-running managers.

A registration statement on Form S-1, including a prospectus, relating to these securities has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering of these securities may be made only by means of a prospectus. Copies of the prospectus may be obtained by contacting: Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, New York 10022, by telephone at (877) 547-6340 or by email at [email protected]; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014 or by email at [email protected]; or BofA Securities, Inc., NC1-004-03-43, Attention: Prospectus Department, 200 North College Street, 3rd Floor, Charlotte, NC 29255 or by email at [email protected].

About Certara

Certara, a global leader in biosimulation based on 2019 revenue, accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.

Certara Contact:

Jieun Choe

Chief Strategy and Marketing Officer

[email protected]

Media Contacts:

Daniel Yunger

Kekst CNC

[email protected]

Elizabeth Tang, Ph.D.

Finn Partners

[email protected]

Investor Relations Contact:

David Deuchler

Gilmartin Group

[email protected]

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Software Networks Internet Pharmaceutical Data Management Medical Devices Technology Genetics Clinical Trials Biotechnology Other Technology Health

MEDIA:

Logo
Logo